+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Viral Vector & Plasmid DNA Manufacturing Market by Service Type (Analytical Testing, Manufacturing Services), Product Type (Plasmid Dna, Viral Vector), Application, Technology Platform, Scale, End User - Global Forecast 2025-2030- Product Image
Viral Vector & Plasmid DNA Manufacturing Market by Service Type (Analytical Testing, Manufacturing Services), Product Type (Plasmid Dna, Viral Vector), Application, Technology Platform, Scale, End User - Global Forecast 2025-2030- Product Image
Sale

Viral Vector & Plasmid DNA Manufacturing Market by Service Type (Analytical Testing, Manufacturing Services), Product Type (Plasmid Dna, Viral Vector), Application, Technology Platform, Scale, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 192 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4986033
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Senior leaders involved in biopharmaceutical manufacturing need actionable intelligence to drive investment and operational decisions within the viral vector and plasmid DNA manufacturing market. This report equips decision-makers with a clear overview of emerging technologies, supply chain dynamics, and market segmentation shaping current and future growth.

Market Snapshot: Viral Vector & Plasmid DNA Manufacturing Market Overview

The Viral Vector & Plasmid DNA Manufacturing Market grew from USD 1.88 billion in 2024 to USD 2.37 billion in 2025. It is expected to continue growing at a CAGR of 25.44%, reaching USD 7.34 billion by 2030.

Scope & Segmentation

  • Service Types: Analytical testing and manufacturing services, including plasmid DNA and viral vector testing, as well as production-focused services for plasmid DNA and viral vectors
  • Product Types: Plasmid DNA constructs and viral vector solutions
  • Applications: Cell therapy, gene therapy, and vaccine development, each requiring tailored manufacturing approaches and quality metrics
  • Technology Platforms: Downstream purification (chromatography, filtration) and upstream processing (fixed bed and stirred tank bioreactors) supporting varying scale requirements
  • Scale: Clinical manufacturing, commercial-scale deployment, and research-focused production
  • End Users: Biopharmaceutical companies, contract development and manufacturing organizations (CDMOs), contract research organizations (CROs), and research institutions with distinct operational priorities
  • Regional Coverage: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, United Arab Emirates, South Africa, and others), Asia-Pacific (China, India, Japan, Australia, Singapore, and broader regional markets)
  • Reviewed Companies: Thermo Fisher Scientific Inc., Merck KGaA, Lonza Group AG, Fujifilm Diosynth Biotechnologies Ltd., Catalent, Inc., WuXi AppTec Co., Ltd., Oxford Biomedica plc, Aldevron, LLC, GenScript Biotech Corporation, Polyplus-transfection SA

Key Takeaways for Senior Decision-Makers

  • Industry-wide demand for advanced biologics drives investment in both process innovation and capacity expansion, establishing viral vector and plasmid DNA manufacturing as critical priorities.
  • Manufacturers are leveraging modular, single-use systems to increase output agility for personalized medicines and small-batch needs, responding efficiently to dynamic clinical and commercial demands.
  • Regulatory pressures continue to escalate, prompting a shift toward heightened quality standards, robust compliance frameworks, and the adoption of next-generation analytical testing protocols.
  • Strategic partnerships between technology providers, academic leaders, and manufacturing organizations enable the commercial scaling of complex therapies and support ongoing research advancements.
  • Digitalization through real-time monitoring and predictive analytics enhances supply chain resilience, supports risk mitigation, and optimizes both upstream and downstream production workflows.
  • Regional strategies must adapt to evolving regulatory conditions, varying talent availability, and supply chain integration levels, especially as Asia-Pacific emerges as a key production hub.

Tariff and Supply Chain Impact

New United States tariffs imposed in 2025 have raised costs for critical components used in both upstream and downstream processes. As a result, manufacturers are re-examining sourcing and logistics to minimize risk, exploring nearshoring, diversifying suppliers, and intensifying process efficiency. Investment in yield enhancement and risk management frameworks, including scenario planning and inventory optimization, supports continuity and cost containment throughout the value chain.

Research Methodology & Data Sources

Findings are derived from in-depth interviews with biopharma executives, process development experts, and quality assurance leaders. These primary insights are validated by secondary research comprising academic literature, regulatory filings, and patent landscape reviews. Analytical modeling and multi-stakeholder reviews underpin quantitative projections and ensure data integrity.

Why This Report Matters

  • Identify growth opportunities across service, product, and application segments to inform strategic investments.
  • Mitigate operational risks by leveraging proven supply chain strategies and technology adoption frameworks featured in the report.
  • Stay ahead of regulatory trends and competitor activities, ensuring well-positioned entry or expansion across target regions.

Conclusion

This analysis delivers a holistic view of the viral vector and plasmid DNA manufacturing landscape. Senior leaders can leverage these insights to steer operational initiatives, strengthen supply chain strategies, and capture emerging market opportunities with confidence.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Advances in single-use bioreactor technology for scalable viral vector production
5.2. Implementation of quality by design frameworks in plasmid DNA manufacturing processes
5.3. Adoption of continuous manufacturing platforms to streamline viral vector production timelines
5.4. Integration of AI-driven process analytical technology for real-time viral vector monitoring
5.5. Development of high-fidelity plasmid backbone constructs to enhance gene therapy potency
5.6. Expansion of customized lentiviral vector capacity through strategic CMO and biotech partnerships
5.7. Optimization of plasmid DNA purification with single-use tangential flow filtration systems
5.8. Regulatory harmonization efforts shaping global supply chains for clinical-grade viral vectors
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Viral Vector & Plasmid DNA Manufacturing Market, by Service Type
8.1. Introduction
8.2. Analytical Testing
8.2.1. Plasmid Dna Testing
8.2.2. Viral Vector Testing
8.3. Manufacturing Services
8.3.1. Plasmid Dna Services
8.3.2. Viral Vector Services
9. Viral Vector & Plasmid DNA Manufacturing Market, by Product Type
9.1. Introduction
9.2. Plasmid Dna
9.3. Viral Vector
10. Viral Vector & Plasmid DNA Manufacturing Market, by Application
10.1. Introduction
10.2. Cell Therapy
10.3. Gene Therapy
10.4. Vaccine Development
11. Viral Vector & Plasmid DNA Manufacturing Market, by Technology Platform
11.1. Introduction
11.2. Downstream Purification
11.2.1. Chromatography
11.2.2. Filtration
11.3. Upstream Processing
11.3.1. Fixed Bed Bioreactor
11.3.2. Stirred Tank Bioreactor
12. Viral Vector & Plasmid DNA Manufacturing Market, by Scale
12.1. Introduction
12.2. Clinical Manufacturing
12.3. Commercial Manufacturing
12.4. Research Manufacturing
13. Viral Vector & Plasmid DNA Manufacturing Market, by End User
13.1. Introduction
13.2. Biopharmaceutical Companies
13.3. CDMOs
13.4. CROs
13.5. Research Institutions
14. Americas Viral Vector & Plasmid DNA Manufacturing Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Viral Vector & Plasmid DNA Manufacturing Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Viral Vector & Plasmid DNA Manufacturing Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Thermo Fisher Scientific Inc.
17.3.2. Merck KGaA
17.3.3. Lonza Group AG
17.3.4. Fujifilm Diosynth Biotechnologies Ltd.
17.3.5. Catalent, Inc.
17.3.6. WuXi AppTec Co., Ltd.
17.3.7. Oxford Biomedica plc
17.3.8. Aldevron, LLC
17.3.9. GenScript Biotech Corporation
17.3.10. Polyplus-transfection SA
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2024 VS 2030 (%)
FIGURE 12. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY SCALE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY SCALE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET: RESEARCHAI
FIGURE 28. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET: RESEARCHSTATISTICS
FIGURE 29. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET: RESEARCHCONTACTS
FIGURE 30. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ANALYTICAL TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ANALYTICAL TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PLASMID DNA TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PLASMID DNA TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY VIRAL VECTOR TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY VIRAL VECTOR TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ANALYTICAL TESTING, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ANALYTICAL TESTING, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY MANUFACTURING SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY MANUFACTURING SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PLASMID DNA SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PLASMID DNA SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY VIRAL VECTOR SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY VIRAL VECTOR SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY MANUFACTURING SERVICES, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PLASMID DNA, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PLASMID DNA, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY VIRAL VECTOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY VIRAL VECTOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CELL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CELL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY GENE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PURIFICATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PURIFICATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY FILTRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY FILTRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PURIFICATION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PURIFICATION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY FIXED BED BIOREACTOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY FIXED BED BIOREACTOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY STIRRED TANK BIOREACTOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY STIRRED TANK BIOREACTOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY SCALE, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY SCALE, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CLINICAL MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CLINICAL MANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY COMMERCIAL MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY COMMERCIAL MANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY RESEARCH MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY RESEARCH MANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CDMOS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CDMOS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CROS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY CROS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ANALYTICAL TESTING, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ANALYTICAL TESTING, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY MANUFACTURING SERVICES, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PURIFICATION, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PURIFICATION, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY SCALE, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY SCALE, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ANALYTICAL TESTING, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ANALYTICAL TESTING, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY MANUFACTURING SERVICES, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PURIFICATION, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PURIFICATION, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY SCALE, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY SCALE, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 121. CANADA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 122. CANADA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 123. CANADA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ANALYTICAL TESTING, 2018-2024 (USD MILLION)
TABLE 124. CANADA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ANALYTICAL TESTING, 2025-2030 (USD MILLION)
TABLE 125. CANADA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2024 (USD MILLION)
TABLE 126. CANADA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY MANUFACTURING SERVICES, 2025-2030 (USD MILLION)
TABLE 127. CANADA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 128. CANADA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 129. CANADA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 130. CANADA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 131. CANADA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 132. CANADA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 133. CANADA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PURIFICATION, 2018-2024 (USD MILLION)
TABLE 134. CANADA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PURIFICATION, 2025-2030 (USD MILLION)
TABLE 135. CANADA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2024 (USD MILLION)
TABLE 136. CANADA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2025-2030 (USD MILLION)
TABLE 137. CANADA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY SCALE, 2018-2024 (USD MILLION)
TABLE 138. CANADA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY SCALE, 2025-2030 (USD MILLION)
TABLE 139. CANADA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 140. CANADA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 141. MEXICO VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 142. MEXICO VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 143. MEXICO VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ANALYTICAL TESTING, 2018-2024 (USD MILLION)
TABLE 144. MEXICO VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ANALYTICAL TESTING, 2025-2030 (USD MILLION)
TABLE 145. MEXICO VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2024 (USD MILLION)
TABLE 146. MEXICO VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY MANUFACTURING SERVICES, 2025-2030 (USD MILLION)
TABLE 147. MEXICO VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 148. MEXICO VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 149. MEXICO VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 150. MEXICO VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 151. MEXICO VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 152. MEXICO VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 153. MEXICO VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PURIFICATION, 2018-2024 (USD MILLION)
TABLE 154. MEXICO VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PURIFICATION, 2025-2030 (USD MILLION)
TABLE 155. MEXICO VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2024 (USD MILLION)
TABLE 156. MEXICO VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2025-2030 (USD MILLION)
TABLE 157. MEXICO VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY SCALE, 2018-2024 (USD MILLION)
TABLE 158. MEXICO VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY SCALE, 2025-2030 (USD MILLION)
TABLE 159. MEXICO VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 160. MEXICO VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 161. BRAZIL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 162. BRAZIL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ANALYTICAL TESTING, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ANALYTICAL TESTING, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY MANUFACTURING SERVICES, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PURIFICATION, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PURIFICATION, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY SCALE, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY SCALE, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 181. ARGENTINA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 182. ARGENTINA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 183. ARGENTINA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ANALYTICAL TESTING, 2018-2024 (USD MILLION)
TABLE 184. ARGENTINA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ANALYTICAL TESTING, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY MANUFACTURING SERVICES, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PURIFICATION, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PURIFICATION, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY SCALE, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY SCALE, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ANALYTICAL TESTING, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ANALYTICAL TESTING, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY MANUFACTURING SERVICES, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PURIFICATION, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PURIFICATION, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY SCALE, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY SCALE, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 223. UNITED KINGDOM VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 224. UNITED KINGDOM VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 225. UNITED KINGDOM VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ANALYTICAL TESTING, 2018-2024 (USD MILLION)
TABLE 226. UNITED KINGDOM VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ANALYTICAL TESTING, 2025-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2024 (USD MILLION)
TABLE 228. UNITED KINGDOM VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY MANUFACTURING SERVICES, 2025-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 230. UNITED KINGDOM VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 232. UNITED KINGDOM VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 234. UNITED KINGDOM VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PURIFICATION, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PURIFICATION, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2025-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY SCALE, 2018-2024 (USD MILLION)
TABLE 240. UNITED KINGDOM VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY SCALE, 2025-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 242. UNITED KINGDOM VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 243. GERMANY VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 244. GERMANY VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 245. GERMANY VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ANALYTICAL TESTING, 2018-2024 (USD MILLION)
TABLE 246. GERMANY VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ANALYTICAL TESTING, 2025-2030 (USD MILLION)
TABLE 247. GERMANY VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2024 (USD MILLION)
TABLE 248. GERMANY VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY MANUFACTURING SERVICES, 2025-2030 (USD MILLION)
TABLE 249. GERMANY VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 250. GERMANY VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 251. GERMANY VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 252. GERMANY VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 253. GERMANY VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 254. GERMANY VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 255. GERMANY VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PURIFICATION, 2018-2024 (USD MILLION)
TABLE 256. GERMANY VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY DOWNSTREAM PURIFICATION, 2025-2030 (USD MILLION)
TABLE 257. GERMANY VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2024 (USD MILLION)
TABLE 258. GERMANY VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2025-2030 (USD MILLION)
TABLE 259. GERMANY VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY SCALE, 2018-2024 (USD MILLION)
TABLE 260. GERMANY VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY SCALE, 2025-2030 (USD MILLION)
TABLE 261. GERMANY VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 262. GERMANY VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 263. FRANCE VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 264. FRANCE VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 265. FRANCE VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ANALYTICAL TESTING, 2018-2024 (USD MILLION)
TABLE 266. FRANCE VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY ANALYTICAL TESTING, 2025-2030 (USD MILLION)
TABLE 267. FRANCE VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2024 (USD MILLION)
TABLE 268. FRANCE VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY MANUFACTURING SERVICES, 2025-2030 (USD MILLION)
TABLE 269. FRANCE VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 270. FRANCE VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 271. FRANCE VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 272. FRANCE VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET SIZE, BY APPLICATION, 2025-2030 (US

Samples

Loading
LOADING...

Companies Mentioned

  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Lonza Group AG
  • Fujifilm Diosynth Biotechnologies Ltd.
  • Catalent, Inc.
  • WuXi AppTec Co., Ltd.
  • Oxford Biomedica plc
  • Aldevron, LLC
  • GenScript Biotech Corporation
  • Polyplus-transfection SA

Table Information

Report AttributeDetails
No. of Pages192
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 2.37 Billion
Forecasted Market Value ( USD ) by 2030 $ 7.34 Billion
Compound Annual Growth Rate25.4%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Viral Vector Manufacturing, Non-Viral Vector Manufacturing and Gene Therapy Manufacturing Market Industry Trends and Global Forecasts to 2035, by Scale of Operation, Type of Vector, Application Area, Therapeutic Area, Type of Manufacturer and Geographical Region - Product Image

Viral Vector Manufacturing, Non-Viral Vector Manufacturing and Gene Therapy Manufacturing Market Industry Trends and Global Forecasts to 2035, by Scale of Operation, Type of Vector, Application Area, Therapeutic Area, Type of Manufacturer and Geographical Region

  • Report
  • 768 Pages
  • Global
From
Viral Vectors & Plasmid DNA Manufacturing Market Report 2025-2035 - Product Image

Viral Vectors & Plasmid DNA Manufacturing Market Report 2025-2035

  • Report
  • 483 Pages
  • Global
From
Viral Vector and Plasmid DNA Manufacturing Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F - Product Image

Viral Vector and Plasmid DNA Manufacturing Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F

  • Report
  • 182 Pages
  • Global
From
Viral Vectors and Plasmid DNA Manufacturing Market Report 2025 - Product Image

Viral Vectors and Plasmid DNA Manufacturing Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Viral Vectors and Plasmid DNA Market Report 2025 - Product Image

Viral Vectors and Plasmid DNA Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.